News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Campoy Carlos
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/30/2023 |
4
| Campoy Carlos (Director) has filed a Form 4 on Zymeworks Inc.
Txns:
| Granted 50,000 options to buy
@ $8.64, valued at
$432k
|
|
03/20/2023 |
4
| Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Sold 1,748 shares
@ $1.9791, valued at
$3.5k
|
|
07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 22,500 shares
@ $0 Granted 135,000 options to buy
@ $4.13, valued at
$557.6k
|
|
10/26/2021 |
4
| Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $5.34, valued at
$213.6k
Granted 30,000 options to buy
@ $0 |
|
06/08/2021 |
4
| Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 3,320 shares
@ $6.086, valued at
$20.2k
|
|
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2020 |
4
| Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 3,101 shares
@ $6.392, valued at
$19.8k
|
|
03/25/2020 |
4
| Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns:
| Granted 350,000 options to buy
@ $4.93, valued at
$1.7M
|
|
10/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2018 |
4
| Campoy Carlos (CFO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns:
| Granted 270,000 options to buy
@ $11.5, valued at
$3.1M
|
|
|
|